Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Pre-irradiation Chemotherapy with BCNU, Cisplatin, and Etoposide for Glioblastoma
NCT00003996Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- May 1999
- Primary completion
- Aug 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carmustine, cisplatin and etoposide in glioblastoma multiforme (GBM), sponsored by Cancer and Leukemia Group B. Primary endpoint: Overall Survival up to 10 years. Started May 1999; status: completed.
02
Drugs
carmustinecisplatinetoposide
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00003996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003996.